The goal of the IVN:DX program is to develop biocompatible nanosensors that provide continuous, noninvasive, and highly accurate measurement of a variety of conditions and substances within the living…
Ended Definitive Contract Awarded Last action
- Contract number
- HR001113C0004
- Awardee
-
Teledyne Flir Defense, Inc. UEI SW2JX7CHDT85 Part of Teledyne Technologies Incorporated
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Obligated
- $1,936,260
Award facts
- Opportunity
-
- In vivo Nanosensors for Diagnostics (IVN:Dx) Award Notice · Posted Jan 28, 2013
- Contract value 100% obligated
- $1,936,260.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 25 offers Basic Research
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Blawnox, PA 15238, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Novation Agreement | $0 | |
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Funding Only Action | $207,788 | |
| Other Administrative Action | $0 | |
| Definitize Change Order | -$37,578 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Funding Only Action | $1,432,716 | |
| Original award | $333,334 |
About this award
This is a cost-plus-fixed-fee definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Teledyne Flir Defense, Inc. (doing business as ICX Technologies), a subsidiary of Teledyne Technologies Incorporated. The contract, worth $1,936,260.16, is for the development of biocompatible nanosensors that can provide continuous, non-invasive, and highly accurate measurement of various conditions and substances within living tissue of animals, plants, and insects using non-toxic materials with limited immunogenicity. This effort is part of DARPA's Intravenous Nanoparticle: Detection and Exploitation (IVN:DX) program, which aims to create advanced biomedical sensing capabilities. The contract has a completion date of September 27, 2023 and does not utilize any set-aside designations.
Description
The goal of the IVN:DX program is to develop biocompatible nanosensors that provide continuous, noninvasive, and highly accurate measurement of a variety of conditions and substances within the living tissue of animals, plants, and insects using non-toxic materials with limited immunogenicity.
Quick answers
Who was awarded contract HR001113C0004?
HR001113C0004 was awarded to Teledyne Flir Defense, Inc. by Defense Advanced Research Projects Agency (Department of Defense) on January 28, 2013.
How much is contract HR001113C0004 worth?
The government has obligated $1,936,260 on HR001113C0004.
Was contract HR001113C0004 competed?
The extent of competition for HR001113C0004 was full and open competition. The government received 25 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award